Evidence around the safety and efficacy of taking GLP-1s in microdoses, is lacking
CKD is associated with an increased risk of developing end-stage kidney disease (ESKD), cardiovascular complications, and mortality [5, 6]
Benefits of Micro-Dosing After Weight Loss 1
Of these, 52.4% (N=11) exclusively used MATRICS, while the remainder also included other cognitive batteries or their subdomains both computerized such as Cogstate (22.2%, N=6), and CANTAB (7.4%, N=2) as well as paper and pencil such as BACS (18.5%, N=5), Six trials (22.2%) either used Cogstate (7.4%, N=2), BACS (7.4%, N=2), or a combination of both (7.4%, N=2) instead of MATRICS
Ultimately, they reflect the fact that levels of drug exposure will vary based on a universal one-size-fits-all dosing regimen